View in EDS

502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer.

Saved in:
Bibliographic Details
Title: 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer.
Authors: Bakouny, Z.1 (AUTHOR), Grover, P.2 (AUTHOR), Labaki, C.1 (AUTHOR), Awosika, J.3 (AUTHOR), Gulati, S.2 (AUTHOR), Hsu, C-Y.4 (AUTHOR), Bilen, M.A.5 (AUTHOR), Eton, O.6 (AUTHOR), Fecher, L.7 (AUTHOR), Hwang, C.8 (AUTHOR), Khan, H.9 (AUTHOR), McKay, R.R.10 (AUTHOR), Ruiz, E.11 (AUTHOR), Weissmann, L.12 (AUTHOR), Thompson, M.A.13 (AUTHOR), Shah, D.14 (AUTHOR), Warner, J.15 (AUTHOR), Shyr, Y.16 (AUTHOR), Choueiri, T.K.1 (AUTHOR), Wise-Draper, T.17 (AUTHOR)
Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS772-S773. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2022.07.630